Your shopping cart is currently empty

Otviciclib (Compound 86) is a CDK inhibitor demonstrating potent antiproliferative effects on solid tumor cells such as HCT116, NCIH82, and DU145, while showing minimal toxicity to normal cells. It effectively induces G2/M phase arrest and apoptosis (apoptosis). Otviciclib exhibits broad-spectrum anticancer activity against cancers like colorectal, pancreatic, and lung cancer.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Otviciclib (Compound 86) is a CDK inhibitor demonstrating potent antiproliferative effects on solid tumor cells such as HCT116, NCIH82, and DU145, while showing minimal toxicity to normal cells. It effectively induces G2/M phase arrest and apoptosis (apoptosis). Otviciclib exhibits broad-spectrum anticancer activity against cancers like colorectal, pancreatic, and lung cancer. |
| Molecular Weight | 621.54 |
| Formula | C26H30Cl2N8O4S |
| Cas No. | 2228039-87-8 |
| Smiles | O=C1N=C(NC2=C1C(=NN2C3=C(Cl)C=C(C=C3Cl)S(=O)(=O)N)N(C)C)CC4=CC=C(C=C4)NC(=O)CN(CC)CC |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.